Several genes are now being identified as potentially important in the biology of prostate cancer development or progression. In particular, genes involved in DNA repair processes are being identified at high rates among men with metastatic prostate cancer. The identification of mutations in these genes currently do not guide cancer screening recommendations, but may inform options for treatment or clinical trials for men with advanced or metastatic prostate cancer. Cancer screening recommendations will usually be based upon personal and family history.